US secretary of state Rex Tillerson says embassy move from Tel Aviv to Jerusalem 'probably not' before 2019
US secretary of state Rex Tillerson said on Friday that the relocation of the US embassy to Jerusalem would probably not take place for at least two years.
Paris: US secretary of state Rex Tillerson said on Friday that the relocation of the US embassy to Jerusalem would probably not take place for at least two years.
"This is not something that is going to happen this year or probably not next year, but the president does want us to move in a very concrete and steadfast way to ensure the embassy is located in Jerusalem when we're able to do so, at the earliest possible time," Tillerson said after talks in Paris with French foreign minister Jean-Yves Le Drian.
Listing the steps involved in moving the embassy from Tel Aviv, Tillerson said the United States needed to acquire a site, develop plans, receive congressional authorisation for the spending "and then actually building the embassy".
He reiterated that the move was not intended to prejudge the outcome of future peace talks between Israel and the Palestinians.
"The president in his statement... did not indicate any final status for Jerusalem. In fact he was, I think, very clear that the final status, including the borders, would be left to the parties to negotiate and decide," he added.
His remarks came as the fallout from President Donald Trump's decision to unilaterally recognise Jerusalem as Israel's capital—renouncing nearly seven decades of US foreign policy—continued to reverberate, with Palestinians staging a "day of rage".
Tillerson also met President Emmanuel Macron, who has joined a host of world leaders in condemning the move.
The treaty, which aimed to repair ties and smoothen bilateral relations between countries during and after the Cold War, was proposed in 1955 by then-US president Dwight Eisenhower
Salman Khurshid slams G-23, says reform not achieved by questioning something one has 'taken advantage of'
Days after Moily stressed the need for a 'major surgery' on the Congress to make it electorally more competitive, Khurshid said these 'wonderful phrases' are not the answer
COVID-19 treatment: Antibody cocktail used to treat Donald Trump is helping patients in India; here's how
Monoclonal antibodies are targeted towards countering a specific antigen, which is nothing but a foreign element that the immune system recognises to be a threat